Ocumension Therapeutics
F:5DG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ocumension Therapeutics
F:5DG
|
CN |
|
W
|
WPP PLC
XMUN:0WP
|
UK |
|
C
|
Cerus Corp
F:CU2
|
US |
|
Playtika Holding Corp
F:8II
|
IL |
Shareholder Yield
Current shareholder yield for 
5DG is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
5DG Price
Ocumension Therapeutics
| Average Annual Return | -12.2% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -68% |
| Market Capitalization | 4.5B EUR |
| Shares Outstanding | 301 842 656 000 |
| Percentage of Shares Shorted |
N/A
|
5DG Return Decomposition
Main factors of price return
Stock Splits
5DG's latest stock split occurred on May 19, 2011
The company executed a 3-for-1 stock split, meaning that for every share held, investors received 3 new shares.
The adjusted shares began trading on May 19, 2011. This was the only stock split in 5DG's history.
